125 related articles for article (PubMed ID: 38613217)
1. Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A
Marín-Aquino LA; Mora-García ML; Moreno-Lafont MC; García-Rocha R; Montesinos-Montesinos JJ; López-Santiago R; Sánchez-Torres LE; Torres-Pineda DB; Weiss-Steider B; Hernández-Montes J; Don-López CA; Monroy-García A
Cell Biochem Funct; 2024 Apr; 42(3):e4010. PubMed ID: 38613217
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-β Production through Its Interaction with A
García-Rocha R; Monroy-García A; Vázquez-Cruz AL; Marín-Aquino LA; Weiss-Steider B; Hernández-Montes J; Don-López CA; Molina-Castillo G; Mora-García ML
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543183
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-β1 Production.
Ávila-Ibarra LR; Mora-García ML; García-Rocha R; Hernández-Montes J; Weiss-Steider B; Montesinos JJ; Lizano Soberon M; García-López P; López CAD; Torres-Pineda DB; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Stem Cells Dev; 2019 Apr; 28(7):477-488. PubMed ID: 30696359
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
García-Rocha R; Monroy-García A; Hernández-Montes J; Weiss-Steider B; Gutiérrez-Serrano V; Del Carmen Fuentes-Castañeda M; Ávila-Ibarra LR; Don-López CA; Torres-Pineda DB; de Lourdes Mora-García M
Cytokine; 2019 Jun; 118():71-79. PubMed ID: 30301599
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.
García-Rocha R; Moreno-Lafont M; Mora-García ML; Weiss-Steider B; Montesinos JJ; Piña-Sánchez P; Monroy-García A
Cytokine; 2015 Dec; 76(2):382-390. PubMed ID: 26343835
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
7. Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses.
Lan Y; Yeung TL; Huang H; Wegener AA; Saha S; Toister-Achituv M; Jenkins MH; Chiu LY; Lazorchak A; Tarcic O; Wang H; Qi J; Locke G; Kalimi D; Qin G; Marelli B; Yu H; Gross AW; Derner MG; Soloviev M; Botte M; Sircar A; Ma H; Sood VD; Zhang D; Jiang F; Lo KM
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858707
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
9. In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.
Montesinos JJ; Mora-García Mde L; Mayani H; Flores-Figueroa E; García-Rocha R; Fajardo-Orduña GR; Castro-Manrreza ME; Weiss-Steider B; Monroy-García A
Stem Cells Dev; 2013 Sep; 22(18):2508-19. PubMed ID: 23656504
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.
Cortés-Morales VA; Chávez-Sánchez L; Rocha-Zavaleta L; Espíndola-Garibay S; Monroy-García A; Castro-Manrreza ME; Fajardo-Orduña GR; Apresa-García T; Gutiérrez-de la Barrera M; Mayani H; Montesinos JJ
Cells; 2023 Mar; 12(7):. PubMed ID: 37048119
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.
Kurago Z; Guo G; Shi H; Bollag RJ; Groves MW; Byrd JK; Cui Y
Front Immunol; 2023; 14():1212209. PubMed ID: 37435071
[TBL] [Abstract][Full Text] [Related]
13. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Zhang T; Liu H; Jiao L; Zhang Z; He J; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Zhang H; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365585
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells.
Aboulkheyr Es H; Bigdeli B; Zhand S; Aref AR; Thiery JP; Warkiani ME
J Cell Physiol; 2021 May; 236(5):3918-3928. PubMed ID: 33145762
[TBL] [Abstract][Full Text] [Related]
15. Co-inhibition of adenosine 2b receptor and programmed death-ligand 1 promotes the recruitment and cytotoxicity of natural killer cells in oral squamous cell carcinoma.
Wang B; Wang T; Yang C; Nan Z; Ai D; Wang X; Wang H; Qu X; Wei F
PeerJ; 2023; 11():e15922. PubMed ID: 37663280
[TBL] [Abstract][Full Text] [Related]
16. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.
Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F
Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
de Streel G; Bertrand C; Chalon N; Liénart S; Bricard O; Lecomte S; Devreux J; Gaignage M; De Boeck G; Mariën L; Van De Walle I; van der Woning B; Saunders M; de Haard H; Vermeersch E; Maes W; Deckmyn H; Coulie PG; van Baren N; Lucas S
Nat Commun; 2020 Sep; 11(1):4545. PubMed ID: 32917858
[TBL] [Abstract][Full Text] [Related]
19. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
20. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
Davies LC; Heldring N; Kadri N; Le Blanc K
Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
